Delivery Order SPE2DB24D1021-SPE2DB25FEZEP
Award Date 8/1/25
Potential Completion Date 8/4/25
Potential Value $4.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pens with a ceiling value of $1,201.20. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-competitive set-aside contract. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication, consistent with AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,458.30 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order represents a non-competitive award issued under a larger contract vehicle and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. Trulicity is a prescription diabetes medication commonly used within military...
- The Defense Logistics Agency awarded a delivery order valued at $10,343.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication widely used in federal healthcare systems, including...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,000.54 for Trulicity 1.5 mg/0.5 ml pens on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within military and federal healthcare systems, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $10,840.88 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 4, 2025. This firm fixed-price delivery order, which will be completed by August 5, 2025, represents a continuation of pharmaceutical supply services to support federal medical procurement needs. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with a ceiling value of $1,719.90. This is a firm fixed price, non-set-aside contract scheduled for completion by July 28, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used for glycemic control, reflecting the company's substantial role in supplying...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens valued at $1,801.80. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes management pharmaceutical, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,073.44 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,628.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 4, 2025. This non-set-aside, firm fixed-price delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. Trulicity is a brand-name diabetes medication commonly used within federal healthcare systems, including military and...
- The Defense Logistics Agency awarded a $1,501.50 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens with an ultimate completion date of August 5, 2025. This non-set-aside contract employs firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...